Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 5 February 2026

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers Health shares surged to $29.44 before falling back to $24.41 after announcing $49 compounded semaglutide pills. Novo Nordisk said it will sue, calling the move illegal mass compounding. The FDA previously warned Hims about misleading claims on compounded semaglutide. Novo’s branded Wegovy pill will cost $199 per month.
5 February 2026
······
Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent shares fell 3.9% to $202.69 in late morning New York trading Thursday after posting fiscal Q2 revenue of $1.69 billion, up 17% from last year. The company expects Q3 revenue between $1.70 billion and $1.84 billion, with non-GAAP EPS forecast at $1.28 to $1.48. Trading volume topped 5.8 million shares after a volatile open. Shares were briefly halted for volatility at 09:38 a.m. ET.
5 February 2026
·····
Qualcomm stock price tumbles on weak forecast as memory crunch hits handset outlook

Qualcomm stock price tumbles on weak forecast as memory crunch hits handset outlook

Qualcomm shares fell 9.5% to $134.68 Thursday morning after the company forecast weaker-than-expected revenue and profit, citing a global memory chip shortage. The stock touched $129.98 as the iShares Semiconductor ETF dropped 1.5%. CEO Cristiano Amon said the supply crunch is hurting handset chip sales, a trend expected to last into 2027. Several major banks cut their price targets following the results.
5 February 2026
·····
Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir shares fell 6.8% to $130.11 Thursday morning, extending a two-day slide that erased most of Tuesday’s rally. The drop follows a 12% plunge Wednesday amid concerns over AI-driven valuations and sector volatility. Director Alexander D. Moore disclosed selling 20,000 shares last week. Investors await U.S. economic data next week that could shift rate expectations for growth stocks.
5 February 2026
·····
Apple stock price hovers near $276 as AI spending jitters hit tech; key dates ahead for AAPL

Apple stock price hovers near $276 as AI spending jitters hit tech; key dates ahead for AAPL

Apple shares slipped 0.02% to $276.45 in early Thursday trading after a 2.6% gain the previous day. The stock moved between $275.89 and $279.40 amid broader tech caution following chip and AI spending concerns. Apple’s dividend record date is Feb. 9, with its annual meeting set for Feb. 24. The company’s market value stands near $3.9 trillion.
5 February 2026
·····
Neste Oyj stock slides as flat 2026 renewables volume outlook jars investors despite profit rebound

Neste Oyj stock slides as flat 2026 renewables volume outlook jars investors despite profit rebound

Neste shares fell 4.65% to 20.51 euros by 14:28 EET after the company forecast flat renewable product volumes for 2026, disappointing investors expecting growth. Q4 comparable EBITDA jumped to 601 million euros from 168 million a year earlier. The company proposed a 0.20 euro per share dividend. Investors await further details on renewables margins during a 3 p.m. Finland call.
5 February 2026
····
Commonwealth Bank share price slides again as banks drag ASX; the next big dates for CBA stock

CBA shares pop after $68m ASIC provision—here’s what markets are watching before Feb 11

Commonwealth Bank shares rose 1.4% to A$159.28 after it disclosed a A$68 million pre-tax provision tied to an ASIC review and A$53 million in non-recurring income items. The update comes ahead of CBA’s half-year results and interim dividend announcement on Feb. 11, as investors weigh the impact of the Reserve Bank’s latest rate hike on mortgage costs.
5 February 2026
······
BP share price slips as oil drops 2% and buyback scrutiny grows before earnings

BP share price slips as oil drops 2% and buyback scrutiny grows before earnings

BP shares fell 0.6% to 474.90 pence in early London trading Thursday, retreating from a one-year high as oil prices dropped and investors awaited earnings. Brent crude slipped 2% to $68.02 a barrel after news of U.S.–Iran talks. BP repurchased 2.7 million shares on Feb. 4 under its ongoing buyback plan. Investors are watching for signals on buybacks and spending when BP reports results Feb. 10.
5 February 2026
····
Johnson & Johnson stock holds near highs as FDA flags Impella heart-pump issue — what to watch next

Johnson & Johnson stock holds near highs as FDA flags Impella heart-pump issue — what to watch next

The FDA issued an early alert on Abiomed Impella RP heart pumps, citing a pressure sensor defect linked to 22 serious injuries but no deaths. Johnson & Johnson shares rose 0.6% to $234.47, holding steady after hours. Traders await further FDA updates and MedTech data at the AF Symposium on Feb. 6. The S&P 500 fell 0.51% while the Dow gained 0.53%.
5 February 2026
·····
GE Aerospace stock price slips after hours as Boeing flags GE9X issue; traders eye next catalyst

GE Aerospace stock price dips as Boeing 777X engine seal issue stays in view

GE Aerospace shares fell 0.5% to $308.33 and slid another 1.1% after hours as the company investigates a possible seal issue in its GE9X engine for Boeing’s 777X. The 777X program remains delayed, with Boeing planning first deliveries in 2027. GE announced new repair facilities and a $300 million investment in Singapore this week.
5 February 2026
······
1 … 3 4 5 6 7 … 282

Stock Market Today

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop